Background and objectives Although associated with increased morbidity and mortality, AKI has not been systematically examined in military personnel injured from combat operations in Iraq and Afghanistan.
Introduction
AKI has been associated with an increase in morbidity and mortality in a wide range of patient populations. Progress in the field of AKI research, however, was hindered by differing definitions. To standardize results, the Acute Dialysis Quality Initiative put forth the Risk-Injury-Failure-Loss-End Stage (RIFLE) criteria (1) . These criteria were later modified by the Acute Kidney Injury Network (AKIN) (2) to reflect the fact that even small changes in serum creatinine portend a worse prognosis (3, 4) .
In two large cohort studies of intensive care (ICU) patients that used the RIFLE criteria, AKI had a prevalence of approximately 36% and was significantly associated with increased mortality (5, 6) . Similar results have been observed in the hospitalized population as a whole (7) , patients undergoing cardiac surgery (8) , and burn patients (9 11) .
To our knowledge, the incidence of AKI and its effect on morbidity and mortality in patients injured in support of combat operations in Iraq and Afghanistan has not been examined. These patients are, however, subject to many potential risk factors for AKI, including hypoperfusion (12), sepsis (6), nephrotoxins (13), intra-abdominal hypertension (14) , transfusions (15) , exposure to iodinated contrast material (16) , burns (9 11) , and trauma (15) . We sought to determine the incidence of AKI, as well as its effect on morbidity and mortality in military casualties.
Materials and Methods
After permission was obtained from the Institutional Review Board, admissions to the US Army Institute of Surgical Research Burn Center from January 2003 to November 2008 were screened. Patients were included if they were military personnel burned in Iraq or Afghanistan. Patients were excluded if they were evacuated from a location other than Iraq or Afghanistan, did not have a recorded creatinine, or were hospitalized ,24 hours. Only a patient's first admission was considered.
Serum creatinine levels were used to classify the stage of AKI based on the AKIN (2) and RIFLE (1) criteria. Because the military does not measure creatinine as part of routine physical examinations, a known baseline was not available. Therefore, the lowest creatinine value in the first 7 days was used to 1,2) . Age, sex, percentage of total body surface area burned (TBSA), percentage of full-thickness burn (FT TBSA), and presence of inhalation injury were retrospectively collected for all patients. Injury severity score (ISS) (17) was taken from a prospectively collected database. To assess other factors potentially associated with mortality, we examined additional variables for patients with $20% TBSA, including the total units of packed red blood cells (PRBCs), traumatic brain injury (TBI), sepsis, and acute respiratory distress syndrome or acute lung injury. PRBCs were quantified using data from our blood bank. Patients were considered to have sepsis if they had positive blood cultures and had the diagnosis of sepsis listed in their medical record. Patients were considered to have TBI, acute respiratory distress syndrome, or acute lung injury if these diagnoses were listed in the medical record.
Multivariate logistic regression analyses were done with independent variables of age, sex, TBSA, FT TBSA, inhalation injury, ISS, and AKIN stage and with dependent variables of in-hospital death, days on mechanical ventilation, days in the ICU, and days in the hospital. Factors that were not significant (P.0.1) were removed from the model via backward elimination. The same analyses were also done for the RIFLE criteria and were repeated with the additional variables collected for the patients with $20% TBSA. Receiver-operating characteristic curves were performed to examine the discriminating power of the models for the outcome of death.
Results
We identified 744 patients. Of these, 28 did not have a measured creatinine level, 3 were not injured in Iraq or Afghanistan, 12 did not have burns, 1 died en route, 1 was being readmitted, and 7 were hospitalized for ,24 hours (Figure 1) . This left 692 patients for analysis. Patient characteristics are summarized in Table 1 . Most of our patients were male (97.5%), and 7.9% were African American. The patients had an average age 6 SD of 25.565. Table 2 .
The prevalence rates of AKI by RIFLE criteria were 14.0% for risk, 5.2% for injury, and 4.6% for failure, with mortality rates of 8.3%, 33.3%, and 62.5%, respectively (Figure 2 ). Patients without AKI by RIFLE had a mortality rate of 0.2%. Similar results were seen for the AKIN criteria, with an AKI prevalence of 19.7% for AKIN-1, 4.0% for AKIN-2, and 6.2% for AKIN-3. Mortality rates for AKIN-1, -2, and -3 were 4.4%, 21.4%, and 65.1%, respectively, compared with 0.2% for patients without AKI (Figure 3) . The baseline creatinine levels were determined by backcalculating the MDRD calculation for 23.6% of patients. More patients in the no-AKI group (by AKIN) had their baseline creatinine levels determined by this method (31.6%) than did the AKI group (4.8%). The majority of patients (57.6%) had AKI identified at admission to our institution, whereas 24.8%, 10%, and 7.6% had AKI blood loss, and exposure to contrast material) are the most likely etiologic factors. Conversely, patients who developed AKI after the first week (17.6%) most likely had complications from their hospitalization (e.g., further contrast material exposure, nephrotoxins, and sepsis) as the cause of their AKI. Patients in the intermediate range, hospital days 2 7 (24.8%), probably had some combination of the preceding factors. Prospective trials will be required to elucidate specific causes more effectively.
This study has a variety of limitations. First, it is a retrospective review and, as such, cannot establish a causeand-effect relationship between the development of AKI and subsequent mortality. Data were collected at a single center and therefore might not be generalizable. The use of the ISS, which was validated in a heterogeneous civilian population, may not be entirely applicable to our population. This study also highlights some of the pitfalls of creatinine as a biomarker of AKI. We were limited to laboratory data obtained at our institution, necessitating the use of the 7-day low as the patient's baseline creatinine.
Although this method has been demonstrated to be superior to back-calculating creatinine using the MDRD equation (a method we also used for some patients), it still overestimates AKIN-1 and underestimates AKIN-2 and -3 (26) . The peak creatinine values seen in our population (1.20, 1.98, and 3.70 mg/dl for AKIN-1, -2, and -3, respectively), as well as the average creatinine at AKI diagnosis (1.39 mg/dl), suggest that our method may have been overly sensitive. Irrespective, our creatinine data demonstrate that we selected subgroups with substantial elevations. Notably, more patients in the non-AKI group had their baseline creatinine values derived by back-calculation than did those in the AKI group (31.6% versus 4.8%), which could introduce bias. The major reason for this discrepancy, however, was that many non-AKI patients were less ill and had only one creatinine measured. It is therefore less likely that significant AKI was missed. The ORs for AKI should be interpreted with caution given the broad confidence intervals. This is partly a result of the low overall number of patients who died (n=41), but is mostly attributable to the fact that only one patient in the non-AKI group died. A few more deaths in the non-AKI group would have narrowed our confidence intervals significantly. Finally, our analysis of morbidity is limited because death is a competing endpoint. One would expect, however, that this would make it more difficult to demonstrate significance.
In summary, after adjustment, AKI was associated with increased morbidity and mortality in military burn casualties. The only other factors significantly associated with mortality were age, ISS, and TBSA. As such, AKI represents the only potentially modifiable risk factor. Although a cause-and-effect relationship is not yet established, the profound effect seen in this cohort supports further allocation of Department of Defense research resources to AKI in combat casualties.
